📋 Tender Overview
Contract awarded for Providing various medications lot-0057, title: brivaracetam (briviact) 100 mg - film-coated tablets, description: brivaracetam (briviact) 100 mg - film-coated tablets. the estimated minimum and maximum quantities are according to specification no. 15223 / 26.06.2025 and annex i to c.s. lot-0058, title: brivaracetam (briviact) 10mg/ml - injection/perfusion solution, description: brivaracetam (briviact) 10mg/ml - injection/perfusion solution. the estimated minimum and maximum quantities are according to specification no. 15223 / 26.06.2025 and annex i to c.s. lot-0166, title: porcine brain hydrolysate 215.2 mg/ml-10ml - injection/concentrate for perfusion solution, description: porcine brain hydrolysate 215.2 mg/ml-10ml - injection/concentrate for perfusion solution. the estimated minimum and maximum quantities are according to specification no. 15223 / 26.06.2025 and annex i to c.s. lot-0187, title: levetiracetam 100mg/ml - concentrate for perfusion solution, description: levetiracetam 100mg/ml - concentrate for perfusion solution. the estimated minimum and maximum quantities are according to specification no. 15223 / 26.06.2025 and annex i to c.s. lot-0221, title: moxifloxacin 400 mg - film-coated tablets, description: moxifloxacin 400 mg - film-coated tablets. the estimated minimum and maximum quantities are according to specification no. 15223 / 26.06.2025 and annex i to c.s. lot-0222, title: moxifloxacin 400 mg / 250 ml - perfusion solution, description: moxifloxacin 400 mg / 250 ml - perfusion solution. the estimated minimum and maximum quantities are according to specification no. 15223 / 26.06.2025 and annex i to c.s. lot-0293, title: rivaroxaban 2.5 mg - film-coated tablets, description: rivaroxaban 2.5 mg - film-coated tablets. the estimated minimum and maximum quantities are according to specification no. 15223 / 26.06.2025 and annex i to c.s. lot-0294, title: rivaroxaban 20 mg - film-coated tablets, description: rivaroxaban 20 mg - film-coated tablets. the estimated minimum and maximum quantities are according to specification no. 15223 / 26.06.2025 and annex i to c.s. lot-0302, title: rotigotine 2 mg - transdermal patches, description: rotigotine 2 mg - transdermal patches. the estimated minimum and maximum quantities are according to specification no. 15223 / 26.06.2025 and annex i to c.s. lot-0314, title: sulodexide 250 mg - soft capsules, description: sulodexide 250 mg - soft capsules. the estimated minimum and maximum quantities are according to specification no. 15223 / 26.06.2025 and annex i to c.s. lot-0329, title: botulinum toxin type a 100 ui - powder for injection solution, description: botulinum toxin type a 100 ui - powder for injection solution. the estimated minimum and maximum quantities are according to specification no. 15223 / 26.06.2025 and annex i to c.s. lot-0339, title: urapidil 25mg/5ml - injection solution, description: urapidil 25mg/5ml - injection solution. the estimated minimum and maximum quantities are according to specification no. 15223 / 26.06.2025 and annex i to c.s. lot-0382, title: beclomethasone + formoterol (foster) 100mg/6 mcg - inhalation solution under pressure, description: beclomethasone + formoterol (foster) 100mg/6 mcg - inhalation solution under pressure. the estimated minimum and maximum quantities are according to specification no. 15223 / 26.06.2025 and annex i to c.s. estimated value excluding vat: 982.98 ron.Providing various medications